Alkermes (ALKS) Return on Capital Employed Growth (1y) (2012 - 2026)
Alkermes (ALKS) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 696.00 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -494.00 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 89.00 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 448.00 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1,397.00 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -1,715.00 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 999.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -2,309.00 |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 9,717.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,715.00 |
| Dec 31, 2025 | -1,203.00 |
| Sep 30, 2025 | 2,256.00 |
| Jun 30, 2025 | 2,643.00 |
| Mar 31, 2025 | 1,767.00 |
| Dec 31, 2024 | 2,252.00 |
| Sep 30, 2024 | -3,029.00 |
| Jun 30, 2024 | -2,465.00 |
| Mar 31, 2024 | 574.00 |
| Dec 31, 2023 | 354.00 |
| Sep 30, 2023 | 2,694.00 |
| Jun 30, 2023 | 1,756.00 |
| Mar 31, 2023 | -504.00 |
| Dec 31, 2022 | -677.00 |
| Sep 30, 2022 | 465.00 |
| Jun 30, 2022 | 669.00 |
| Mar 31, 2022 | 1,160.00 |
| Dec 31, 2021 | 1,397.00 |
| Sep 30, 2021 | -817.00 |
| Jun 30, 2021 | -459.00 |